(Press-News.org) Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic azithromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.
Bronchiectasis is characterized by abnormal widening of the bronchi (air tubes that branch deep into the lungs) and can cause recurrent lung infections, a disabling cough, shortness of breath, and coughing up blood. "If progressive, this process may lead to respiratory failure and the need for lung transplantation or to death," according to background information in the study. Macrolide (a class of antibiotics) antibiotics have antibacterial and anti-inflammatory properties that conceivably would provide effective treatment of bronchiectasis. These antibiotics have been shown beneficial in treating cystic fibrosis (CF), and findings from small studies suggest a benefit in non-CF bronchiectasis.
Josje Altenburg, M.D., of the Medical Centre Alkmaar, the Netherlands, and colleagues conducted a multicenter trial to investigate whether 1 year of low-dose macrolide treatment added to standard therapy is effective in reducing exacerbation frequency in patients with non-CF bronchiectasis. The randomized, placebo-controlled trial was conducted between April 2008 and September 2010 in 14 hospitals in the Netherlands among 83 outpatients with non-CF bronchiectasis and 3 or more lower respiratory tract infections in the preceding year. Patients received azithromycin (250 mg daily) or placebo for 12 months.
Forty-three participants (52 percent) received azithromycin and 40 (48 percent) received placebo and were included in the modified intention-to-treat analysis. A total of 117 exacerbations treated with antibiotics were reported during 1 year of treatment, 78 of which occurred in the placebo group. "During the treatment period, the median [midpoint] number of exacerbations in the azithromycin group was 0, compared with 2 in the placebo group. Of the 40 participants receiving placebo, 32 (80 percent) had at least 1 exacerbation during the study period. In the 43 participants receiving azithromycin, 20 (46.5 percent) had at least 1 exacerbation in the same period, yielding an absolute risk reduction of 33.5 percent. The number of patients needed to treat with azithromycin to maintain clinical stability was 3.0," the authors write.
"Gastrointestinal adverse effects occurred in 40 percent of patients in the azithromycin group and in 5 percent in the placebo group but without need for discontinuation of study treatment. A macrolide resistance rate of 88 percent was noted in azithromycin-treated individuals, compared with 26 percent in the placebo group."
"We conclude that macrolide maintenance therapy was effective in reducing exacerbations in patients with non-CF bronchiectasis. In this trial, azithromycin treatment resulted in improved lung function and better quality of life but involved an increase in gastrointestinal adverse effects and high rates of macrolide resistance," the authors write.
###
(JAMA. 2013;309(12):1251-1259; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Azithromycin may provide benefit for treatment of respiratory disorder
2013-03-27
ELSE PRESS RELEASES FROM THIS DATE:
Antibiotic may provide benefit for treatment of respiratory disorder
2013-03-27
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.
David J. Serisier, M.B.B.S., D.M., F.R.A.C.P., of Mater Adult Hospital, South Brisbane, Australia, and colleagues tested the hypothesis that low-dose erythromycin would reduce pulmonary exacerbations in patients with non-CF bronchiectasis with a history of frequent exacerbations.
The study consisted of ...
Review article examines sublingual immunotherapy for treatment of allergic rhinitis and asthma
2013-03-27
In an examination of a type of treatment for allergic rhinitis and asthma that is used in Europe but not approved by the U.S. Food and Drug Administration, researchers found moderate strength in the evidence from previous studies to support the use of sublingual immunotherapy for the treatment of these conditions, according to an article in the March 27 issue of JAMA. Sublingual immunotherapy involves administration of aqueous allergens under the tongue for local absorption to desensitize the allergic individual over an extended treatment period to diminish allergic symptoms.
Allergic ...
Pining for a beetle genome
2013-03-27
The sequencing and assembly of the genome of the mountain pine beetle, Dendroctonus ponderosae, is published online this week in Genome Biology. The species is native to North America, where it is currently wreaking havoc in an area of forest ten times larger than previous outbreaks. This paper determines genes that may be involved in colonizing the trees, such as enzymes for degrading plant cell walls, and identifies potential sex chromosomes in the beetle.
D. ponderosae is a species of bark beetle, native to North America, that attacks various species of pine trees. ...
Sequencing without PCR reduces bias in measuring biodiversity
2013-03-27
DNA barcode sequencing without the amplification of DNA by PCR beats the problem of false positives which can inflate estimates of biodiversity, finds a study published in BioMed Central and BGI Shenzhen's open access journal GigaScience. This method tested on a bulk 'squashome' of mixed insect samples is also able rapidly and cost-effectively estimate biomass.
Often samples collected in the field are too small be sequenced directly. Traditionally, to get round this problem, DNA from the sample is amplified using multiple cycles of PCR. However this process is highly ...
Squished bug genomics: Insect goo aids biodiversity research
2013-03-27
March 27th, 2013, Hong Kong, China – GigaScience (a BGI and BioMed Central open access journal) announces the publication of an article that presents a new method for assessing and understanding biodiversity that uses a DNA-soup made from crushed-up insects and next generation sequencing technology. This bulk-collected insect goo has the potential to rapidly and cost-effectively reveal the diversity and make-up of both known and unknown species collected in a particular time and place. The new method devised by Xin Zhou and colleagues at BGI Shenzhen, China, is a more accurate ...
Researchers question evaluation methods for protected areas in the Amazon
2013-03-27
The indicators currently being used to guide policy and investments into protected areas in the Amazon may not be having the desired effect.
This is according to a new study published today, 27 March, in IOP Publishing's journal Environmental Research Letters, which has analysed 66 protected areas in the Brazilian Amazon and performed a critical analysis of the tool – the Rapid Assessment and Prioritisation of Protected Area Management (RAPPAM) – that is used to manage, prioritise and assess the effectiveness of conservation efforts in these areas.
The researchers, ...
Overweight and obese women at higher risk of adverse neonatal and maternal outcomes
2013-03-27
Overweight and obese women are more likely to require specialist medical care during their pregnancy due to the increased risk of adverse neonatal and maternal outcomes, finds a new study published today (27 March) in BJOG: An International Journal of Obstetrics and Gynaecology.
The study, carried out by a team from Queen's University Belfast and Belfast Health and Social Care Trust, found that maternal obesity has significant health implications contributing to increased morbidity and mortality for both mother and baby. With worldwide obesity rates having doubled over ...
Many cancer institution websites lack nutritional guidance, others give mixed messages
2013-03-27
PHILADELPHIA—Radiation oncologists at Thomas Jefferson University Hospital are stressing the need for evidence-based, standardized guidelines on dietary recommendations for cancer patients—and with good reason. A new analysis revealed that online dietary recommendations for cancer patients, if even present on an institution's website, appear to be consistently inconsistent.
A review of all 21 of the National Comprehensive Cancer Network (NCCN) member institutions found that only four provided nutritional guidelines, with seven linking to external sites. What's more, ...
Paranoia persists in mugging victims for months after attack, study finds
2013-03-27
Being mugged or randomly attacked in the street often leaves people paranoid and distrustful of others long after the attack, according to a study published today. The research highlights a previously under-recognised consequence of physical assault which will help to inform therapy for those seeking help.
In the study, four out of five victims reported that since the assault they were more fearful of other people than they wanted to be. Importantly the study identified what led to excessive mistrust lasting over the next six months. Being attacked close to home, feeling ...
Hospital remains most common place of death for cancer patients in England
2013-03-27
In England, hospital is still the most common place for patients with cancer to die but an increase in home and hospice deaths since 2005 suggests that the National End of Life Care Programme (a Programme to promote the rollout of national end-of-life care initiatives) has helped more people to die at their preferred place of death, according to a UK study funded by the National Institute for Health Research Health Services and Delivery Research (NIHR HS&DR) Programme, published in this week's PLOS Medicine.
In a large analysis led by Dr Wei Gao and Professor Irene Higginson ...